NCT07644702 WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women
| NCT ID | NCT07644702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Breast Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2028-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-05 with a primary completion date of 2028-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial tests how well the Women's Engagement for Cancer Awareness, Resources, and Education (WE-CARE) community health forums work to increase breast cancer screening and clinical trial participation for rural and low income women. Despite advances in breast cancer diagnosis and treatment in the past decade, rural-dwelling and underserved women, and Black, Indigenous, and people of color continue to experience low rates of breast cancer screening. Since the survival rate for breast cancer is largely dependent on stage at which it is diagnosed, later stage breast cancer is correlated to a poorer prognosis and higher mortality rate. The WE-CARE community health forms address structural barriers through culturally tailored educational sessions on breast cancer risk, screening and clinical trials, survivor storytelling to humanize cancer and research and patient navigation to facilitate mammogram screening and address barriers. The WE-CARE community health forums may be an effective way to increase breast cancer screening and clinical trial participation for rural and low income women.
Eligibility Criteria
Inclusion Criteria: * Female * Be between the ages of 50 and 74 years * Have no prior history of breast cancer screening (i.e., who have either never received a mammogram or have not had one in the past five years) * Reside in a rural community in Wisconsin or belong to low income (self-reported) * Be able to speak and understand English or Spanish * Be willing and able to provide informed consent Exclusion Criteria: * Women who have received a mammogram within the past five years * Have a current or prior diagnosis of breast cancer * Are currently undergoing treatment for any active malignancy * Have cognitive or psychiatric impairments that, in the judgment of the study team, would preclude meaningful participation
Contact & Investigator
Pravesh Sharma, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic Health System-Eau Claire Clinic
Frequently Asked Questions
Who can join the NCT07644702 clinical trial?
This trial is open to female participants only, aged 50 Years or older, up to 74 Years, studying Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07644702 currently recruiting?
Yes, NCT07644702 is actively recruiting participants. Contact the research team at sharma.pravesh@mayo.edu for enrollment information.
Where is the NCT07644702 trial being conducted?
This trial is being conducted at Eau Claire, United States.
Who is sponsoring the NCT07644702 clinical trial?
NCT07644702 is sponsored by Mayo Clinic. The principal investigator is Pravesh Sharma, MD at Mayo Clinic Health System-Eau Claire Clinic. The trial plans to enroll 50 participants.